Posts by Robert S. Bader, M.D., Dermatologist
DERMATOLOGISTS PERFORM NEARLY RISK-FREE COSMETIC PROCEDURES
According to a study published in JAMA Dermatology on Nov 5, “minimally invasive cosmetic procedures are nearly risk-free.” Such procedures included fillers, neurotoxins, and the use of laser and energy devices–performed by 23 dermatologists at eight centers across the US. It has been well-studied that Dermatologists have an outstanding safety record with minimally-invasive and non-invasive…
Read MoreNON-SURGICAL FACELIFT, BROWLIFT, AND NECKLIFT – ULTHERAPY
Ultherapy® is the only non-surgical, FDA-approved, non-invasive, skin tightening treatment for the neck, eyebrow, and under the chin. Using ultrasound energy, Ultherapy safely stimulates the deep supportive layers of the skin, including those that are typically addressed with a facelift, without disturbing the surface layer of the skin. The result: tightening of the skin in…
Read MoreRESTYLANE SILK EXPECTED TO BE RELEASED SOON – GALDERMA’S NEWEST FILLER TREATMENT FOR THE LIPS AND LIP LINES
Since being approved by the FDA in June 2014, cosmetic surgeons have been awaiting the release to market of Galderma’s newest product to their already extensive cosmetic line consisting of Restylane, Perlane, Dysport, and Sculptra. This variation on the “old Restylane” is smoother and is expected to flow easier being a good choice for the…
Read MoreOBAMACARE – AFFORDABLE CARE ACT — MANY UNFULFILLED PROMISES
As the dust is settling, we are finding that the affordable care act (aka “Obamacare” or ACA) has left many unable to continue care with their existing healthcare providers. The promise that one can keep their existing plan and doctors is not exactly true, leaving many scrambling to find a new doctor. The truth is…
Read MoreVIAGRA LINKED TO INCREASED MELANOMA RISK
According to an article published online April 7, 2014 in JAMA Internal Medicine, the use of sildenafil (Viagra, Pfizer) is associated with an increased risk of developing invasive malignant melanoma. Other medications used to treat erectile dysfunction, including Cialis and Levitra, were not studied as they were not approved at the time that this study…
Read MoreDRUG APPROVED FOR INOPERABLE MELANOMA
Keytruda (pembrolizumab) was finally approved for the treatment of inoperable malignant melanoma. Testing was never completed as it performed so well in the early clinical trials.
Read MoreNEW FILLER IS FDA APPROVED
JUVÉDERM VOLUMA™ XC is a hyaluronic acid filler that has been FDA approved for volume correction in the cheeks. This new product will compete with the already popular Radiesse™ and is used to give more volume to the cheeks and/or fill in hollows. It appears that this product will be priced higher than Radiesse™ and,…
Read MoreNEW MELANOMA DRUG LOOKS PROMISING FOR STAGE III AND IV MELANOMA PATIENTS
51% Of Patients Benefited In Phase II Trial. Forbes (10/30, Fortonbury) reports that in a study published in Annals of Surgical Oncology, a new cancer drug, PV-10, 51% of stage III and IV melanoma patients benefited during a phase II trial, and achieved total cancer disappearance in 26%. In addition, the response tended to be both…
Read MoreNEW PRODUCT APPROVED FOR FACIAL REDNESS – ROSACEA
The FDA has approved a new product that is the first topical treatment specifically indicated for persistent facial redness that is seen in many patients with rosacea. The topical treatment works by constricting the dilated blood vessels and lasts up to 12 hours.
Read MoreNEW STUDY SHOWS THAT POOR SLEEP HABITS MAY HAVE DIRECT IMPACT ON ONE’S SKIN
The Cleveland Plain Dealer (7/23, Townsend) reports a study that shows that people who don’t get enough sleep are more likely to have skin that ages more quickly and be less healthy.
Read More